Results 81 to 90 of about 39,940 (191)

Baculovirus vector.

Uirusu, 1987
openaire   +3 more sources

EFECTO DE LA INFECCIÓN CON GRANULOVIRUS EN EL DESARROLLO DE Tecia solanivora (Lepidoptera: Gelechiidae) EFFECT OF GRANULO VIRUSES INFECTION ON THE DEVELOPMENT OF Tecia solanivora (Lepidoptera: Gelechiidae)

Revista Facultad Nacional de Agronomía Medellín, 2009
El control biológico de Tecia solanivora mediante el uso del granulovirus de Phthorimaea operculella originario del Perú es uno de los principales componentes para su manejo a nivel mundial.
Carlos Espinel Correal, Alba Marina Cotes Prado, Laura Villamizar Rivero   +2 more
doaj  

Development of VP1 based indirect ELISAs for BK and JC polyomaviruses with seroprevalence assessment and cross reactivity evaluation. [PDF]

Sci Rep
Alipour AH, Fallah FH, Kiasari BA.
europepmc   +1 more source

Continuous production of recombinant adeno-associated virus in the insect cell/baculovirus expression vector system. [PDF]

Mol Ther Adv
Joseph J, Destro F, Yuan A, Antov D, Chen W, Song S, Theriault M, Yuan C, Sansom A, Lundin C, Burns T, Hamed HA, Morales P, Fan JX, Rodriguez AR, Sichuma S, McCracken C, Neufeld C, Wolfrum JM, Srinivasan P, Barone PW, Sinskey AJ, Braatz RD, Springs SL.   +23 more
europepmc   +1 more source

Immunogenicity Analysis of PCV3 Capsid Highly Expressed Using Baculovirus. [PDF]

Int J Mol Sci
Zhang B, Chao L, Cai Y, Li Y.
europepmc   +1 more source

Engineering Chondroitinase-Free Baculovirus-Insect Cell Expression System for Efficient Synthesis of Chondroitin Sulphates. [PDF]

Microb Biotechnol
Li J, Tian Y, She L, Liu Z, Zhou Y, Wang Y, Zhang J, Zhu L, Tan H, Li J.   +9 more
europepmc   +1 more source

Development of a 12-Valent HPV L1 Virus-like Particle Vaccine Using an Enhanced Baculovirus Expression System. [PDF]

Vaccines (Basel)
Kim JD, Kim EH, Lee JH, Kim SY, Oh JM, Cho Y, Kim H, Gwak W, Woo SD, Han BK, Choi JB.   +10 more
europepmc   +1 more source

Baculoviruses exploit the mitotic kinase CDK1 to disrupt the nuclear lamina. [PDF]

PLoS Pathog
Mo M, Yu S, Yang Y, Liu J, Yang K, Yuan M.   +5 more
europepmc   +1 more source

A continuous viral vaccine biomanufacturing platform utilizing multiple bioreactor configurations. [PDF]

J Biol Eng
Sargunas J, Priem B, Carman D, Sarvari T, Nold NM, Sharma V, Pekosz A, Heldt CL, Betenbaugh M.   +8 more
europepmc   +1 more source

Molecular characterization of rabbit hemorrhagic disease virus type 2 and long-lasting protection conferred by a VLP-based vaccine. [PDF]

BMC Vet Res
Wang Y, Qiao P, Wu H, Tong X, Wang T, Wang L, Yang Y, Su X, Liu C, Chen Y, Wang L, Wang M, Xi X, Wang F, Pang W, Liu Y, Tian K.   +16 more
europepmc   +1 more source